• $228.8M
    Market Cap
  • 170.66%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Income Statement
Total Operating Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
0
N/A
0
N/A
0
N/A
0
-100.00%
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
-5.8M
-51.60%
-11.9M
-6.35%
-12.7M
-13.27%
-14.6M
-54.28%
Depreciation and Amortization Expense
5,442
0.00%
5,442
0.00%
5,442
N/A
N/A
N/A
Total Operating Expenses
15.1M
-30.87%
21.8M
-5.50%
23.1M
-8.37%
25.2M
-44.38%
Operating Profit
-15.1M
-30.87%
-21.8M
-5.50%
-23.1M
-8.37%
-25.2M
-44.38%
Interest Income
948,122
-25.48%
1.3M
-11.48%
1.4M
+158.09%
556,946
+3,272.16%
Interest Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Income and Expense and Net
948,122
-25.48%
1.3M
-11.48%
1.4M
+158.09%
556,946
+3,272.16%
Total Nonoperating Income and Expense
26.6M
0.00%
26.6M
N/A
N/A
N/A
N/A
N/A
Income before Taxes
-15.1M
-30.87%
-21.8M
-5.50%
-23.1M
-28.00%
-32.1M
-37.91%
Income Taxes
N/A
N/A
N/A
N/A
N/A
N/A
-1.8M
0.00%
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-293.4M
-20,492.68%
1.4M
+104.80%
-30.0M
-6.55%
-32.1M
-35.66%
Net Income from Continuing Operations Applicable to Common
-293.4M
-20,492.68%
1.4M
+104.80%
-30.0M
-6.55%
-32.1M
-37.91%
Basic EPS and Net Income
-34.67
-18,347.37%
0.19
+104.12%
-4.61
-23.29%
-6.01
+413.68%
Diluted EPS and Net Income
-34.67
-18,347.37%
0.19
+104.12%
-4.61
-23.29%
-6.01
+413.68%
Basic Weighted Average Shares
8.5M
+11.82%
7.6M
+16.33%
6.5M
+21.84%
5.3M
-87.50%
Diluted Weighted Average Shares
8.5M
+11.75%
7.6M
+16.41%
6.5M
+21.84%
5.3M
-87.50%
Balance Sheet
Cash and Cash Equivalents
82.3M
+285.27%
21.4M
-47.79%
40.9M
+13.35%
36.1M
-40.59%
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
82.3M
+285.27%
21.4M
-47.79%
40.9M
+13.35%
36.1M
-40.59%
Total Current Assets
83.1M
+273.16%
22.3M
-46.98%
42.0M
+4.59%
40.2M
-35.44%
Accumulated Depreciation
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
0
-100.00%
5,442
-50.00%
10,884
-33.33%
16,326
N/A
Total Long-Term Assets
0
-100.00%
5,442
-50.00%
10,884
-33.33%
16,326
+10.25%
Total Assets
98.0M
+163.76%
37.1M
-34.72%
56.9M
+3.29%
55.1M
-28.57%
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Current Liabilities
2.3M
-19.26%
2.8M
-15.08%
3.3M
+142.49%
1.4M
-51.13%
Total Long-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
171.5M
N/A
N/A
N/A
N/A
N/A
7,533
-99.79%
Total Liabilities
233.8M
+272.00%
62.8M
-26.38%
85.4M
+13.64%
75.1M
+8.63%
Retained Earnings
-688.8M
+74.21%
-395.4M
-0.36%
-396.8M
+8.18%
-366.8M
+9.59%
Total Stockholders Equity
-140.7M
+447.80%
-25.7M
-9.71%
-28.5M
+42.12%
-20.0M
-351.07%
Total Shares Outstanding
43.3M
+518.79%
7.0M
0.00%
7.0M
+30.96%
5.3M
-87.50%
Cash Flow
Cash from Operating Activities
-13.5M
-30.89%
-19.6M
+32.23%
-14.8M
-40.01%
-24.6M
+0.18%
Capital Expenditures
N/A
N/A
N/A
N/A
16,326
0.00%
16,326
N/A
Cash from Investing Activities
0
N/A
0
+100.00%
-16,326
0.00%
-16,326
-100.07%
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
74.5M
+279.78%
19.6M
0.00%
19.6M
+392,074,120.00%
-5
-100.00%
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Return on Assets
-434.34%
-14,294.07%
3.06%
+105.71%
-53.59%
+10.32%
-48.57%
-34.43%
Return on Equity
352.58%
+6,734.64%
-5.31%
-104.29%
123.78%
-76.78%
532.99%
+423.80%
Revenue Growth
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Current Ratio
36.28
+362.18%
7.85
-37.57%
12.57
-56.87%
29.15
+32.12%
Cash Ratio
35.93
+377.17%
7.53
-38.52%
12.25
-53.25%
26.20
+21.57%
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow